Veranex Announces Appointments of New CEO and COO
Veranex announced the appointment of industry veteran Tom Daulton as chief executive officer (CEO). David Dockhorn, who previously served in this role, is assuming the newly created role of chief operating officer (COO).
Read more about the appointments here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
